These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11243411)

  • 1. An antiprion effect of the anticytoskeletal drug latrunculin A in yeast.
    Bailleul-Winslett PA; Newnam GP; Wegrzyn RD; Chernoff YO
    Gene Expr; 2000; 9(3):145-56. PubMed ID: 11243411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupting the cortical actin cytoskeleton points to two distinct mechanisms of yeast [PSI+] prion formation.
    Speldewinde SH; Doronina VA; Tuite MF; Grant CM
    PLoS Genet; 2017 Apr; 13(4):e1006708. PubMed ID: 28369054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast.
    Ness F; Ferreira P; Cox BS; Tuite MF
    Mol Cell Biol; 2002 Aug; 22(15):5593-605. PubMed ID: 12101251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of prion loss after Hsp104 inactivation in yeast.
    Wegrzyn RD; Bapat K; Newnam GP; Zink AD; Chernoff YO
    Mol Cell Biol; 2001 Jul; 21(14):4656-69. PubMed ID: 11416143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal domain of yeast Hsp104 chaperone is dispensable for thermotolerance and prion propagation but necessary for curing prions by Hsp104 overexpression.
    Hung GC; Masison DC
    Genetics; 2006 Jun; 173(2):611-20. PubMed ID: 16582428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic study of interactions between the cytoskeletal assembly protein sla1 and prion-forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae.
    Bailleul PA; Newnam GP; Steenbergen JN; Chernoff YO
    Genetics; 1999 Sep; 153(1):81-94. PubMed ID: 10471702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curing of yeast [PSI+] prion by guanidine inactivation of Hsp104 does not require cell division.
    Wu YX; Greene LE; Masison DC; Eisenberg E
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12789-94. PubMed ID: 16123122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 104 (Hsp104)-mediated curing of [
    Zhao X; Rodriguez R; Silberman RE; Ahearn JM; Saidha S; Cummins KC; Eisenberg E; Greene LE
    J Biol Chem; 2017 May; 292(21):8630-8641. PubMed ID: 28373280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperones that cure yeast artificial [PSI+] and their prion-specific effects.
    Kushnirov VV; Kryndushkin DS; Boguta M; Smirnov VN; Ter-Avanesyan MD
    Curr Biol; 2000 Nov; 10(22):1443-6. PubMed ID: 11102806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of latrunculin-A, an actin monomer-binding drug.
    Ayscough K
    Methods Enzymol; 1998; 298():18-25. PubMed ID: 9751867
    [No Abstract]   [Full Text] [Related]  

  • 11. The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation.
    Ferreira PC; Ness F; Edwards SR; Cox BS; Tuite MF
    Mol Microbiol; 2001 Jun; 40(6):1357-69. PubMed ID: 11442834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Cell Asymmetry Apparatus and Ribosome-Associated Chaperones in the Destabilization of a
    Howie RL; Jay-Garcia LM; Kiktev DA; Faber QL; Murphy M; Rees KA; Sachwani N; Chernoff YO
    Genetics; 2019 Jul; 212(3):757-771. PubMed ID: 31142614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small heat shock protein Hsp31 cooperates with Hsp104 to modulate Sup35 prion aggregation.
    Aslam K; Tsai CJ; Hazbun TR
    Prion; 2016 Nov; 10(6):444-465. PubMed ID: 27690738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal levels of ribosome-associated chaperones cure two groups of [PSI+] prion variants.
    Son M; Wickner RB
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26298-26306. PubMed ID: 33020283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor.
    Paushkin SV; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD
    EMBO J; 1996 Jun; 15(12):3127-34. PubMed ID: 8670813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp104 disaggregase at normal levels cures many [
    Gorkovskiy A; Reidy M; Masison DC; Wickner RB
    Proc Natl Acad Sci U S A; 2017 May; 114(21):E4193-E4202. PubMed ID: 28484020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation.
    Paushkin SV; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD
    Mol Cell Biol; 1997 May; 17(5):2798-805. PubMed ID: 9111351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion properties of the Sup35 protein of yeast Pichia methanolica.
    Kushnirov VV; Kochneva-Pervukhova NV; Chechenova MB; Frolova NS; Ter-Avanesyan MD
    EMBO J; 2000 Feb; 19(3):324-31. PubMed ID: 10654931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae.
    Derkatch IL; Bradley ME; Zhou P; Chernoff YO; Liebman SW
    Genetics; 1997 Oct; 147(2):507-19. PubMed ID: 9335589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interaction between Sla1p and Sla2p plays a role in regulating actin dynamics and endocytosis in budding yeast.
    Gourlay CW; Dewar H; Warren DT; Costa R; Satish N; Ayscough KR
    J Cell Sci; 2003 Jun; 116(Pt 12):2551-64. PubMed ID: 12734398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.